IP-Se-06, a Selenylated Imidazo[1,2-
Journal
Oxidative medicine and cellular longevity
ISSN: 1942-0994
Titre abrégé: Oxid Med Cell Longev
Pays: United States
ID NLM: 101479826
Informations de publication
Date de publication:
2022
2022
Historique:
received:
21
11
2021
revised:
01
02
2022
accepted:
04
02
2022
entrez:
1
4
2022
pubmed:
2
4
2022
medline:
5
4
2022
Statut:
epublish
Résumé
Glioblastoma multiforme (GBM) is a notably lethal brain tumor associated with high proliferation rate and therapeutic resistance, while currently effective treatment options are still lacking. Imidazo[1,2-
Identifiants
pubmed: 35360199
doi: 10.1155/2022/3710449
pmc: PMC8964227
doi:
Substances chimiques
Pyridines
0
MTOR protein, human
EC 2.7.1.1
Proto-Oncogene Proteins c-akt
EC 2.7.11.1
TOR Serine-Threonine Kinases
EC 2.7.11.1
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
3710449Informations de copyright
Copyright © 2022 Daniela C. dos Santos et al.
Déclaration de conflit d'intérêts
The authors declare that there are no conflicts of interests.
Références
FEBS J. 2017 Oct;284(20):3437-3454
pubmed: 28834297
Comp Biochem Physiol C Toxicol Pharmacol. 2019 Aug;222:59-64
pubmed: 31028929
J Immunol Methods. 1983 Dec 16;65(1-2):55-63
pubmed: 6606682
Crit Rev Clin Lab Sci. 2006;43(2):143-81
pubmed: 16517421
Cell Cycle. 2003 Jul-Aug;2(4):339-45
pubmed: 12851486
Onco Targets Ther. 2018 Nov 02;11:7763-7775
pubmed: 30464524
Biochem Biophys Res Commun. 2018 Sep 10;503(3):1291-1297
pubmed: 30017191
Nat Rev Cancer. 2003 Oct;3(10):721-32
pubmed: 13130303
Oxid Med Cell Longev. 2015;2015:495305
pubmed: 25793019
Eur J Med Chem. 2021 Jun 5;218:113384
pubmed: 33799070
Anticancer Agents Med Chem. 2021;21(6):703-715
pubmed: 32723262
PLoS One. 2014 Jul 23;9(7):e103432
pubmed: 25054228
Anticancer Res. 2009 Aug;29(8):2993-6
pubmed: 19661306
Arch Toxicol. 2021 Apr;95(4):1179-1226
pubmed: 33792762
J Pharm Pharmacol. 2021 Mar 27;73(5):673-681
pubmed: 33772293
Chemistry. 2016 Aug 8;22(33):11854-62
pubmed: 27388454
Oncogene. 2019 Dec;38(50):7473-7490
pubmed: 31444413
Cell. 2011 Mar 4;144(5):646-74
pubmed: 21376230
Bioorg Med Chem Lett. 2019 Sep 15;29(18):2551-2558
pubmed: 31420269
Cancer Lett. 2009 Nov 18;285(1):23-7
pubmed: 19481864
Mol Cell Biochem. 2019 Dec;462(1-2):195-206
pubmed: 31493190
Bioorg Med Chem. 2021 Jun 15;40:116186
pubmed: 33971490
Biophys J. 2003 Nov;85(5):3350-7
pubmed: 14581236
Nat Commun. 2018 Jul 27;9(1):2949
pubmed: 30054476
Cancer Biol Ther. 2008 Sep;7(9):1321-5
pubmed: 18836294
Nat Rev Clin Oncol. 2020 Jul;17(7):395-417
pubmed: 32203277
Biomed Res Int. 2020 Aug 25;2020:4929053
pubmed: 32908894
Curr Top Med Chem. 2017;17(2):238-250
pubmed: 27237332
Anal Biochem. 1976 May 7;72:248-54
pubmed: 942051
Methods Enzymol. 1999;300:226-39
pubmed: 9919525
Nature. 2008 May 29;453(7195):662-6
pubmed: 18449193
J Med Chem. 2020 May 14;63(9):4603-4616
pubmed: 32223240
J Neurooncol. 2020 Jan;146(1):9-23
pubmed: 31776900
Biochim Biophys Acta. 2015 Aug;1850(8):1642-60
pubmed: 25459512
Nat Rev Drug Discov. 2009 Jul;8(7):579-91
pubmed: 19478820
Science. 1997 Sep 5;277(5331):1497-501
pubmed: 9278511
J Integr Med. 2013 Mar;11(2):116-24
pubmed: 23506692
J Biochem Mol Toxicol. 2021 Mar;35(3):e22663
pubmed: 33125183
Bioorg Med Chem Lett. 2018 Aug 15;28(15):2647-2651
pubmed: 30042044
Nat Commun. 2021 Jan 8;12(1):177
pubmed: 33420027
Lancet Oncol. 2009 May;10(5):459-66
pubmed: 19269895
Cancer Cell. 2015 Feb 9;27(2):211-22
pubmed: 25620030
Sci Rep. 2017 Mar 03;7:42717
pubmed: 28256516
PLoS One. 2015 Oct 08;10(10):e0140131
pubmed: 26447477
Curr Oncol Rep. 2019 Mar 5;21(4):30
pubmed: 30835007
Anal Biochem. 1976 Jul;74(1):214-26
pubmed: 962076
Cancer Lett. 2013 Jan 1;328(1):152-9
pubmed: 22929971
Oncol Lett. 2019 Jul;18(1):830-837
pubmed: 31289560
Int J Mol Sci. 2018 Sep 22;19(10):
pubmed: 30248992
Neuroreport. 2018 Dec 12;29(18):1578-1585
pubmed: 30371540
Biochim Biophys Acta. 2006 Sep;1763(9):958-68
pubmed: 16905201
Nat Protoc. 2006;1(5):2315-9
pubmed: 17406473
Bioorg Chem. 2019 Sep;90:103042
pubmed: 31226469
Molecules. 2010 Oct 21;15(10):7292-312
pubmed: 20966875
Int J Oncol. 2018 Sep;53(3):973-986
pubmed: 30015880
J Cell Biochem. 2019 Jun;120(6):10248-10272
pubmed: 30592328
J Cell Mol Med. 2004 Oct-Dec;8(4):455-64
pubmed: 15601574
Oncotarget. 2017 Jun 20;8(25):40817-40831
pubmed: 28489580
Nucleic Acids Res. 2021 Jul 2;49(W1):W5-W14
pubmed: 33893803
Eur J Med Chem. 2018 Jul 15;155:503-515
pubmed: 29908443
Carcinogenesis. 2020 Jun 17;41(4):405-416
pubmed: 32347301
Oxid Med Cell Longev. 2020 May 28;2020:5417024
pubmed: 33093936
Anticancer Agents Med Chem. 2014 Feb;14(2):313-8
pubmed: 24506460
Int J Mol Sci. 2020 Feb 07;21(3):
pubmed: 32046099
Chemistry. 2018 Mar 15;24(16):4173-4180
pubmed: 29243330
Methods Cell Biol. 1995;46:153-85
pubmed: 7541883
ChemMedChem. 2016 Jun 6;11(11):1117-21
pubmed: 27218427
Yakugaku Zasshi. 2021;141(3):315-321
pubmed: 33642497
Cell Death Differ. 2018 Jan;25(1):104-113
pubmed: 29149101
Oncogene. 2012 Apr 12;31(15):1949-62
pubmed: 21909130
Chem Commun (Camb). 2019 Dec 19;56(2):179-196
pubmed: 31782422
Cell Death Differ. 2018 Mar;25(3):486-541
pubmed: 29362479
Chemistry. 2020 Apr 6;26(20):4461-4466
pubmed: 31816129
J Org Chem. 2019 Oct 4;84(19):12632-12638
pubmed: 31357859
Oncotarget. 2014 Jun 15;5(11):3662-72
pubmed: 25004403
Methods Mol Biol. 2016;1425:63-83
pubmed: 27311462
Curr Pharm Des. 2011;17(23):2411-20
pubmed: 21827416
J Med Chem. 2020 Mar 26;63(6):3028-3046
pubmed: 32069401
J Biol Chem. 1951 Nov;193(1):265-75
pubmed: 14907713
Expert Opin Investig Drugs. 2019 Nov;28(11):977-988
pubmed: 31594388
N Engl J Med. 2005 Mar 10;352(10):987-96
pubmed: 15758009
JAMA Oncol. 2016 Nov 01;2(11):1460-1469
pubmed: 27310651
J Cheminform. 2018 Jun 26;10(1):29
pubmed: 29943074